Solar Industries India
Solar Industries India makes industrial explosives and detonators, and has rapidly expanded into defense products - rockets, missiles, ammunition and drones - for the Indian armed forces and export markets.
- P/E ~74x
- ROE ~33%
- Defense order book ₹17,568 cr
- Promoter 73%, no pledge
- Stock up 650% in 5 yrs
Updated on 6 Nov 2026 · Data as of 5 Nov 2026
Get this report as a PDF free, straight to your inbox.
Snapshot
- Share price
- ₹18,520.00
- 5 Nov 2026
- 52-week range
- ₹11,765.05 – ₹22,455.00
- All-time peak
- ₹22,455.00
- 8 Sept 2026 · −17.5% from peak
- Dividend yield
- 0.06%
- Price history since
- 2006
- About 20 years of prices
What's happening
Q2 FY27 results (quarter ended Sep 2026) were reported on 3 November 2026: revenue of ₹3,519 crore (up 69% year-on-year) and net profit of ₹650 crore (up roughly 80% year-on-year), with EBITDA margin at 29.02%. The order book stands at ₹20,178 crore, of which ₹17,568 crore (87%) is defense-related. Management said it now expects to beat its full-year FY27 revenue guidance of ₹14,000 crore.
In plain terms
This company used to be known mainly for making explosives for mining and construction, but defense products - things like rockets and ammunition for the Indian military - are now nearly 30% of its sales and growing much faster than the rest of the business. The tension: results this quarter were genuinely strong, yet the stock is still 17.5% below its September 2026 peak, which tells you the market had priced in even more. Revenue and profit actually dipped slightly from the previous quarter (Q1 FY27), even though they're sharply higher than a year ago - a reminder that defense order execution can be lumpy quarter to quarter. At nearly 74 times earnings, a lot of future growth is already baked into the price.
Quarters
Q2 FY27 (Sep 2026): revenue ₹3,519 crore (+69% YoY, but -4.1% versus Q1 FY27's ₹3,668 crore); PAT ₹650 crore (+80% YoY, -2.4% versus Q1's ₹666 crore); EBITDA margin 29.02%, up from 27.95% a year ago and from 27.70% last quarter. H1 FY27 totals: revenue ₹7,187 crore (+70% YoY), PAT ₹1,316 crore (+84% YoY). No exceptional or one-off items were flagged by management or in filings for this quarter - the margin improvement is attributed to a richer defense mix (defense revenue rose to 29% of quarterly sales from 24% a year earlier). Management now guides to roughly 29% EBITDA margin for the full year, above its original 28% target.
Performance
Heads-up on splits: Solar Industries India has split its shares or issued bonus shares before (most recently 5-for-1 on 13 Jul 2016). A sudden price drop around a split date is usually just the price adjusting for the extra shares, not a crash.
Share price
+38.5% over 1 year
Returns by period
| Period | Solar Industries India | Nifty 50 |
|---|---|---|
| 3 months | +0.1% | −0.4% |
| 1 year | +38.5% | −3.8% |
| 3 years | +232.2% | +26.4% |
| 5 years | +651.0% | +35.8% |
₹100 invested on 8 Nov 2021 became…
- Solar Industries India₹751
- Nifty 50₹136
Returns have been exceptional versus the market: +38.5% over 1 year, +232% over 3 years and +651% over 5 years, against the Nifty's -3.8%, +26.4% and +35.8% respectively. There was a 5-for-1 stock split back in 2016, but that is a decade old and already reflected in the price series used here, so it has no bearing on recent moves. The stock is currently ₹18,520, down 17.5% from its ₹22,455 peak hit on 8 September 2026, but still more than 50% above its 52-week low of ₹11,765 - this is a pullback within a strong structural uptrend, not a crash and not a corporate-action artifact.
Dividend
Paid in the last 12 months
₹11.00 per share
Dividend yield
0.06%
Dividend yield is the last 12 months of dividends divided by today's share price. A 0.1% yield means every ₹100 of Solar Industries India shares paid about ₹0.1 in dividends over the past year. Past payouts can change.
Recent dividends
| Date | Per share |
|---|---|
| 28 Jul 2026 | ₹11.00 |
| 8 Jul 2025 | ₹10.00 |
| 4 Jul 2024 | ₹8.50 |
| 9 Jun 2023 | ₹8.00 |
| 27 May 2022 | ₹7.50 |
| 18 Aug 2021 | ₹6.00 |
| 3 Sept 2020 | ₹6.00 |
| 18 Jul 2019 | ₹7.00 |
Valuation
At a TTM P/E of about 74x and P/B of about 22x, the stock is expensive by almost any conventional yardstick. Why it is expensive is clear: the market is pricing in a defense order book (₹17,568 crore) that already exceeds the company's full-year revenue guidance, plus margin expansion and a return profile (ROE 32.6%, ROCE 38.1%) that few industrial companies match. Whether that expense is justified is a separate question - it depends entirely on whether defense orders keep converting to revenue at this pace for several more years. Any stumble in execution or order timing would leave little valuation cushion.
Growth
Growth here is both volume- and margin-led, which is the more durable combination. Revenue is growing roughly 70% year-on-year on rising defense deliveries (volume), while EBITDA margin is simultaneously expanding (27.95% to 29.02% YoY) because the defense mix carries better margins than the legacy explosives business. This looks like a structural mix shift rather than a one-off pricing or commodity tailwind.
Health
Profits are converting into solid returns on capital - ROCE of 38.1% and ROE of 32.6% - alongside conservative leverage (gross debt/equity of about 0.24, net closer to 0.09). The balance sheet risk is low. The real risk here is business/execution risk: a roughly ₹12,000 crore multi-year capex program (including a subsidiary's ₹12,700 crore Nagpur defense hub commitment) needs to be built out and ramped, and defense order conversion needs to stay on schedule for the current growth rate to hold.
Ownership
Promoters (the Nuwal family) hold 73.15% of the company, unchanged recently, with zero shares pledged as of FY26 - a clean picture. There were some intra-family transfers (a family trust taking a larger stake, a family member making an inter-se/gift transfer) that moved shares within the promoter group but did not reduce the aggregate promoter holding. Institutional ownership includes FIIs (~6.1%) and mutual funds (~12%), including SBI, Kotak and Axis schemes. No well-known individual investor - no Jhunjhunwala, Kacholia, Kedia or similar name - appears on the shareholder register; that should be stated plainly rather than implied.
The View
The one thing to watch
Whether the ₹17,568 crore defense order book converts into revenue on schedule over the next 2-3 quarters, and whether new large orders (such as further Pinaka-class rocket contracts) materialize as management has signaled - any delay would test the current premium valuation directly.
Strengths
- +Order book of ₹20,178 crore, 87% (₹17,568 crore) defense-related, already exceeds the company's full-year FY27 revenue guidance of ₹14,000 crore
- +EBITDA margin rose to 29.02% in Q2 FY27 from 27.95% a year earlier, now ahead of management's original 28% full-year target
- +ROCE of 38.1% and ROE of 32.6% alongside conservative leverage (gross debt/equity ~0.24)
- +Defense now makes up 29% of quarterly revenue, up from 24% a year ago, structurally lifting the overall margin profile
Watchpoints
- !Valuation at ~74x trailing earnings and ~22x book leaves little room for a growth or margin disappointment
- !Revenue and profit both dipped slightly quarter-on-quarter in Q2 FY27 versus Q1 FY27, despite strong year-on-year growth - a sign that defense order execution can be uneven
- !A roughly ₹12,000 crore multi-year capex program, including a subsidiary's ₹12,700 crore Nagpur defense hub, carries execution and ramp-up risk
- !The stock is already 17.5% below its September 2026 peak even after a results beat, suggesting the market is recalibrating how much future growth is already priced in
How sure are we about the data? · Moderate
Q2 FY27 revenue, EBITDA and PAT figures were cross-checked across screener.in, BusinessToday, Investywise and Upstox, with the ₹650 crore PAT figure corroborated by the majority of sources against one outlier (₹617 crore) that was set aside. Valuation ratios (P/E, P/B, ROE, ROCE, debt/equity) are from screener.in. Shareholding percentages were cross-checked between valueresearchonline.com and screener.in, though the DII vs mutual-fund split differs slightly between sources, likely due to classification differences rather than a factual conflict. Exact announcement dates for several reported defense order wins (₹6,084 crore, ₹2,039 crore, ₹1,400 crore) could not be confirmed to fall within the Aug-Nov 2026 window and should be treated as approximate. The next quarterly results date and next AGM date were not yet formally announced as of 6 November 2026.
Keep it for later
Get the Solar Industries India report as a PDF
The full report, neatly laid out with charts and tables, sent to your inbox. Handy to read offline or share.
Reports are refreshed every quarter, about three days after each company announces its results.
Ticker Tales is not a SEBI-registered investment adviser or research analyst. This report is for learning only and is not investment advice. Data as of 5 Nov 2026.